Metraipolis › archive › dc_dc0f866798d1
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived… — Europe PMC PMID:40938473
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40938473
- DOI
- 10.1007/s00280-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:42:18.632Z
- SHA-256 of the archived text
785cca70687db0fe072a2a53df400875baf1497359f00ab0710793673193592c- Stable URL of this page
https://metraipolis.com/documento/dc_dc0f866798d1
How to cite
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived… — Europe PMC PMID:40938473 — Europe PMC (en), https://europepmc.org/article/MED/40938473 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc0f866798d1 (Metraipolis archive dc_dc0f866798d1, sha256 785cca70687db0fe072a2a53df400875baf1497359f00ab0710793673193592c)
BibTeX
@misc{dcdc0f866798d1,
title = {RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived… — Europe PMC PMID:40938473},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40938473},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc0f866798d1; sha256 785cca70687db0fe072a2a53df400875baf1497359f00ab0710793673193592c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40938473. Agents can read the archived copy with the MCP tool read_document.